Benchling is the industry-leading software platform for life science R&D. Purpose-built for biologics, Benchling combines an Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and a molecular biology design suite into a single, unified, cloud-based platform. It’s trusted by over 200,000 scientists — from pioneering academics and high-growth startups to all of the world’s top 50 biopharma companies.
Sector: Life Sciences
Farapulse
Farapulse is a medical device company developing a novel approach to treating a range of arrhythmias using pulsed electric field. Farapulse was acquired by Boston Scientific in 2021.
Beam Therapeutics
Beam Therapeutics (NASDAQ: BEAM) is pioneering the use of CRISPR base editing to develop precision genetic medicines that treat disease, one letter at a time.
Tempest Therapeutics
Tempest Therapeutics (Nasdaq: TPST) is a development-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways.
NFlection Therapeutics
NFlection Therapeutics is a biopharmaceutical company focused on the development of therapies for Neurofibromatosis 1 (NF1), and other disorders.
Plasmagen Biosciences
Plasmagen is an Indian biopharma company that specializing exclusively in Plasma Protein Therapy.
Curegenix
Curegenix is a Chinese leader in discovery and development of novel drugs in stem cell related diseases.
Cytek Biosciences
Cytek Biosciences Inc. (NASDAQ: CTBK) is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capabilities.
Indalo Therapeutics
Indalo Therapeutics, a preclinical biotechnology company dedicated to developing therapies for fibrosis, is formed with an experienced team, strong IP, and robust portfolio of drug candidates.
Avalyn Pharmaceuticals
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.